Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Edelman Joseph
Relationship:   Former 10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   42    
Direct Shares   630,171    

Indirect Shares

   332,164,708      
Direct Value   $1,466,262    

Indirect Value

   $2,852,575,947      
Total Shares   332,794,879      
Total Value   $2,854,042,209      


Aegerion Pharmaceuticals, Inc. $0 Nautilus Biotechnology, Inc $1,466,262 Aegerion Pharmaceuticals, Inc. $0 Nautilus Biotechnology, Inc $1,466,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    79   
    21    

     Stock price went up :
    50   
    11    
     Stock price went down :
    29   
    10    
   
     Gain/Loss Ratio :
   1.7   
   1.1   
     Percentage Gain/Loss :
   13.4%
 197.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2008-06-23 0 2008-06-23 6,387,546    Premium*  
            Synageva BioPharma Corp GEVA 10% Owner 0 2011-11-02 0    Premium*  
            Aegerion Pharmaceuticals, Inc. AEGR 10% Owner 2012-11-01 133,133 2012-11-29 2,595,293    Premium*  
            Acelrx Pharmaceuticals Inc ACRX 10% Owner 0 2017-06-19 4,533,728    Premium*  
            Amicus Therapeutics Inc FOLD 10% Owner 0 2018-10-03 20,724,424    Premium*  
            VBI Vaccines Inc VBIV 10% Owner 0 2014-07-25 2,610,356    Premium*  
            Aldeyra Therapeutics, Inc. ALDX 10% Owner 0 2024-04-05 9,275,851    Premium*  
            Aravive Inc ARAV 10% Owner 0 2017-09-22 2,099,563    Premium*  
            Kadmon Holdings, Llc KDMN 10% Owner 0 2019-11-18 14,636,334    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2017-09-29 0 2018-08-10 4,070,357    Premium*  
            Global Blood Therapeutics, Inc. GBT 10% Owner 2017-12-19 0 2017-12-19 4,889,066    Premium*  
            Corium International, Inc. CORI 10% Owner 2018-01-16 0 2018-10-12 2,724,686    Premium*  
            Albireo Pharma Inc ALBO 10% Owner 2018-01-25 0 2022-10-13 1,939,723    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 2018-01-30 0 2024-01-11 6,906,646    Premium*  
            La Jolla Pharmaceutical Co LJPC 10% Owner 2018-02-13 0 2019-01-08 2,253,376    Premium*  
            Motus Gi Holdings Inc MOTS 10% Owner 2018-02-16 0 2021-01-22 2,660,542    Premium*  
            Quotient Ltd QTNTQ 10% Owner 2018-05-22 0 2022-10-31 7,945,211    Premium*  
            Dova Pharmaceuticals, Inc. DOVA 10% Owner 2018-06-04 0 2019-11-12 0    Premium*  
            Meiragtx Holdings Plc MGTX 10% Owner 2018-06-08 0 2023-05-05 11,281,103    Premium*  
            Crinetics Pharmaceuticals, Inc. CRNX 10% Owner 2018-07-20 0 2022-04-18 5,321,032    Premium*  
            Agile Therapeutics Inc AGRX 10% Owner 2018-07-26 0 2021-10-13 21,654,485    Premium*  
            Verrica Pharmaceuticals Inc. VRCA 10% Owner 2018-06-19 0 2023-12-29 7,099,182    Premium*  
            Athenex, Inc. ATNX 10% Owner 2019-05-06 0 2020-09-14 13,532,467    Premium*  
            ADMA Biologics Inc ADMA 10% Owner 2019-05-21 0 2021-09-30 13,262,375    Premium*  
            Foamix Pharmaceuticals Ltd FOMX 10% Owner 0 2019-07-29 11,203,881    Premium*  
            Lyra Therapeutics, Inc. LYRA Director, 10% Owner 2020-05-05 0 2023-05-31 12,757,563    Premium*  
            VYNE Therapeutics Inc VYNE 10% Owner 2020-06-09 0 2021-08-16 4,935,057    Premium*  
            Leap Therapeutics, Inc. LPTX 10% Owner 2020-06-22 0 2020-06-22 8,476,496    Premium*  
            Athira Pharma, Inc. ATHA Director, 10% Owner 0 2023-12-29 5,402,964    Premium*  
            Cerevel Therapeutics Holdings, I... CERE Director 2020-10-20 0 2024-02-20 10,794,876    Premium*  
            Scynexis Inc SCYX 10% Owner 2021-01-20 0 2021-01-22 1,800,000    Premium*  
            Landos Biopharma, Inc. LABP Director, 10% Owner 0 2021-02-09 17,960,839    Premium*  
            Astria Therapeutics, Inc ATXS Director 0 2024-02-01 6,485,420    Premium*  
            Prometheus Biosciences, Inc. RXDX 10% Owner 2021-03-16 0 2021-03-16 3,314,032    Premium*  
            Rain Therapeutics Inc. RAIN 10% Owner 2021-04-27 0 2021-10-12 2,487,019    Premium*  
            Nautilus Biotechnology, Inc NAUT 10% Owner 2021-05-24 497,038 2021-12-08 9,111,151    Premium*  
            Isoplexis Corp ISO 10% Owner 2021-10-12 0 2021-10-12 3,554,587    Premium*  
            Lianbio LIAN Director, 10% Owner 0 2024-02-15 57,575,533    Premium*  
            Acrivon Therapeutics, Inc. ACRV 10% Owner 0 2024-04-11 5,360,858    Premium*  
            Chembio Diagnostics Inc CEMI Former 10% Owner 2023-04-04 0 2023-04-27 0    Premium*  
            Soleno Therapeutics Inc SLNO 10% Owner 0 2023-06-06 2,207,753    Premium*  
            Cargo Therapeutics, Inc. CRGX Former 10% Owner 2023-11-14 0 2023-11-14 333,333    Premium*  
* Premium Members only  

Records found :    304         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 13
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ATNX Athenex, Inc. 10% Owner   –       –       •   2019-12-24 4 B $14.39 $1,060,514 I/I 73,698 11,532,467 1.5 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2020-09-10 4 B $11.24 $2,248,000 I/I 200,000 11,732,467 1.5 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2020-09-14 4 B $11.00 $19,800,000 I/I 1,800,000 13,532,467 1.5 -
ATXS Astria Therapeutics, Inc Director   –       •       •   2021-01-28 3 IO $0.00 $0 I/I 0 2,476,924 -
ATXS Astria Therapeutics, Inc Director   –       •      –    2022-12-19 4 B $11.01 $9,999,998 I/I 908,265 1,038,309 2.1 %
ATXS Astria Therapeutics, Inc Director   –       •      –    2023-10-16 4 B $6.51 $6,999,997 I/I 1,074,608 1,611,699 2.1 %
ATXS Astria Therapeutics, Inc Director   –       •      –    2023-12-21 4 B $6.20 $4,588,000 I/I 740,000 2,392,371 2.1 %
ATXS Astria Therapeutics, Inc Director   –       •      –    2024-02-01 4 B $12.09 $29,999,522 I/I 2,481,350 4,873,721 2.1 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-04 4 B $0.44 $86,213 I/I 195,938 3,868,600 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-04 3 IO $0.00 $0 I/I 0 3,672,662 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-05 4 B $0.45 $97,875 I/I 217,500 4,086,100 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-06 4 B $0.44 $149,160 I/I 339,000 4,425,100 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-11 4 B $0.44 $56,760 I/I 129,000 4,554,100 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-13 4 B $0.45 $63,060 I/I 140,134 4,694,234 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-14 4 B $0.45 $5,175 I/I 11,500 4,705,734 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-17 4 B $0.45 $2,160 I/I 4,800 4,710,534 1.42 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-18 4 B $0.45 $7,078 I/I 15,800 4,726,334 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-19 4 B $0.45 $61,376 I/I 137,000 4,863,334 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-20 4 B $0.45 $25,200 I/I 56,000 4,919,334 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-21 4 B $0.45 $31,450 I/I 70,200 4,989,534 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-24 4 B $0.45 $17,778 I/I 39,506 5,029,040 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-25 4 B $0.45 $60,184 I/I 133,742 5,162,782 1.5 %
CEMI Chembio Diagnostics Inc Former 10% Owner   –       –      –    2023-04-27 4 D $0.45 $2,323,252 I/I (5,162,782) 0 0 -
CERE Cerevel Therapeutics Hold... Director   –       •      –    2020-10-20 4 B $10.00 $1,141,000 I/I 114,100 114,100 2.1 %
CERE Cerevel Therapeutics Hold... Director   –       •      –    2020-10-21 4 B $10.09 $435,838 I/I 43,195 157,295 2.1 %
  304  Records found
  1   2   3   4   5  6   7   8   9   10   11   12   13      
  Page 5 of 13  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us